Edition:
India

Cara Therapeutics Inc (CARA.OQ)

CARA.OQ on NASDAQ Stock Exchange Global Market

16.64USD
1:30am IST
Change (% chg)

$0.02 (+0.12%)
Prev Close
$16.62
Open
$16.71
Day's High
$17.12
Day's Low
$16.39
Volume
119,791
Avg. Vol
256,955
52-wk High
$28.49
52-wk Low
$11.12

Chart for

About

Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by focusing on kappa opioid receptors. It is developing a class of product candidates that target the body's peripheral nervous system. The... (more)

Overall

Beta: 3.11
Market Cap(Mil.): $444.74
Shares Outstanding(Mil.): 32.58
Dividend: --
Yield (%): --

Financials

Cara Therapeutics signs licensing deal with Vifor Fresenius, shares surge

Shares of Cara Therapeutics surged more than 20 percent on Wednesday after it signed a licensing agreement with Vifor Fresenius Medical Care Renal Pharma Ltd that could give the U.S. drug developer up to $470 million in milestone payments.

23 May 2018

BRIEF-Cara Therapeutics Reports Q1 Loss Per Share $0.51

* CARA THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

10 May 2018

BRIEF-Cara Therapeutics Reports Q4 Loss Per Share $0.43

* CARA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

16 Mar 2018

Earnings vs. Estimates